Federal Government Backs Tourists in Atlantic City Casino Hotel Suit — Update
By Ben Glickman
Federal regulators are backing two tourists who have accused major Atlantic City casino-hotels of collusion, the latest push by competition officials to curb the use of algorithms in price-setting.
The Federal Trade Commission and the Justice Department's Antitrust Division filed a statement of interest in the case on Thursday, arguing the hotels' use of the same algorithm may represent collusion.
The case, originally brought in May 2023 by two tourists, named Caesars Entertainment and MGM Resorts International as defendants, among others. The plaintiffs alleged that the competing hotels violated antitrust law by knowingly using the same price-setting algorithm.
The two agencies argued that the company's use of the algorithm can still violate antitrust law even if the companies never directly communicated, responding to one of the legal arguments used by the defendants. The FTC and DOJ also said in their statement that the companies could have still violated U.S. law by using the algorithm to set a starting price, even if they ended up charging different amounts.
The agencies have thrown their weight behind similar cases in the real estate industry.
The Justice Department filed a statement of interest in a case involving landlords and real-estate software company RealPage last year. Tenants alleged that the use of RealPage's algorithmic pricing system violated antitrust laws.
The FTC and Justice Department argued against the dismissal of a case involving the pricing-software company Yardi earlier this month.
Government lawyers have said that antitrust laws don't require proof of direct communication between competitors. They argue the law applies to "tacit" agreements, including competitors leaving it up to a common entity to set prices.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
March 28, 2024 18:59 ET (22:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel in Earnings Season
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth